Physician profile
Jared Ward
NPI 1669907309
$1,595.81
in general payments reported to CMS, 2019-2025
9 companies · $1,277 in 2025
The $1,277 reported for 2025 was more than what 81% of Critical Care Medicine (Internal Medicine) providers received nationally (typical 2025 total: $189).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $39.71 · 2023: $92.07 · 2024: $187 · 2025: $1,277.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,263 · Travel and Lodging: $293.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,263.10 |
| Travel and Lodging | $293.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $1,055.97 | 2024-2025 | Impella |
| Atricure, INC. | $254.21 | 2024-2025 | Synergy Ablation System, Atricure Cryoice Cryosphere Cryoablation System |
| Edwards Lifesciences Corporation | $126.57 | 2022-2024 | |
| Becton, Dickinson and Company | $37.12 | 2025 | Hemosphere |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $29.68 | 2023 | Lifevest |
| Vapotherm INC | $27.60 | 2025 | Vapotherm |
| Abbott Laboratories | $23.61 | 2024 | Navitor |
| Genentech USA, INC. | $20.60 | 2024 | Perjeta, Phesgo, Kadcyla |
| Solventum Corporation | $20.45 | 2025 | Prevena, V.A.C. Veraflo, V.A.C.Ulta |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jared Ward listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.